Exploring the promise of robot-assisted single-port transvesical radical prostatectomy: Insights from intermediate-term follow-up
SPTVRARP optimizes perioperative outcomes. It shortens hospital stays, reduces opioid use, facilitates early catheter removal, and accelerates urinary continence recovery while ensuring oncologic safety.
Authors
- Roxana Ramos‐Carpinteyro (ORCID: https://orcid.org/0000-0002-5848-4357)
- Zeyad Schwen (ORCID: https://orcid.org/0000-0001-7334-3600)
- Jaya S. Chavali (ORCID: https://orcid.org/0000-0002-3044-2745)
- Adriana M. Pedraza (ORCID: https://orcid.org/0000-0003-3275-7019)
- Rubén Olivares (ORCID: https://orcid.org/0000-0002-4895-7106)
- Carter Mikesell (ORCID: https://orcid.org/0000-0002-8151-7217)
- Jane Nguyen (ORCID: https://orcid.org/0000-0002-1653-4942)
- Alp Tuna Beksaç (ORCID: https://orcid.org/0000-0001-6742-0040)
- Nicolas Soputro (ORCID: https://orcid.org/0000-0002-5419-0327)
- Christopher Weight (ORCID: https://orcid.org/0000-0001-9381-959X)
- Jihad H. Kaouk
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.urolonc.2025.08.015
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00